Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type |Pathology location|Pathology Description|
2002-1-1|n/a,n/a|Sequence:1, Age:56,Type:none (controls),Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:n/a|498 (0 in ERA)|Mouse|Mouse, B6C3F1|Male|Young Adult|Lifespan study with full histopathology|No information on individuals available for this study
2002-1-2|n/a,n/a|Sequence:1, Age:56,Type:gamma-rays Cs-137,Quantity:0.05,Unit:milligrays per day,Application:External exposure, Remarks:continuous exposure 22h/d for 400 d total dose 20 mGy|495 (0 in ERA)|Mouse|Mouse, B6C3F1|Male|Young Adult|Lifespan study with full histopathology|No information on individuals available for this study
2002-1-3|n/a,n/a|Sequence:1, Age:56,Type:gamma-rays Cs-137,Quantity:1,Unit:milligrays per day,Application:External exposure, Remarks:continuous exposure 22h/d for 400 d total dose 400 mGy|500 (0 in ERA)|Mouse|Mouse, B6C3F1|Male|Young Adult|Lifespan study with full histopathology|No information on individuals available for this study
2002-1-4|n/a,n/a|Sequence:1, Age:56,Type:gamma-rays Cs-137,Quantity:20,Unit:milligrays per day,Application:External exposure, Remarks:continuous exposure 22h/d for 400 d total dose 8000 mGy|499 (0 in ERA)|Mouse|Mouse, B6C3F1|Male|Young Adult|Lifespan study with full histopathology|No information on individuals available for this study
2002-1-5|n/a,n/a|Sequence:1, Age:56,Type:none (controls),Quantity:0,Unit:unit code not relevant,Application:not applicable or not supplied, Remarks:n/a|500 (0 in ERA)|Mouse|Mouse, B6C3F1|Female|Young Adult|Lifespan study with full histopathology|No information on individuals available for this study
2002-1-6|n/a,n/a|Sequence:1, Age:56,Type:gamma-rays Cs-137,Quantity:0.05,Unit:milligrays per day,Application:External exposure, Remarks:continuous exposure 22h/d for 400 d total dose 20 mGy|495 (0 in ERA)|Mouse|Mouse, B6C3F1|Female|Young Adult|Lifespan study with full histopathology|No information on individuals available for this study
2002-1-7|n/a,n/a|Sequence:1, Age:56,Type:gamma-rays Cs-137,Quantity:1,Unit:milligrays per day,Application:External exposure, Remarks:continuous exposure 22h/d for 400 d total dose 400 mGy|497 (0 in ERA)|Mouse|Mouse, B6C3F1|Female|Young Adult|Lifespan study with full histopathology|No information on individuals available for this study
2002-1-8|n/a,n/a|Sequence:1, Age:56,Type:gamma-rays Cs-137,Quantity:20,Unit:milligrays per day,Application:External exposure, Remarks:continuous exposure 22h/d for 400 d total dose 8000 mGy|500 (0 in ERA)|Mouse|Mouse, B6C3F1|Female|Young Adult|Lifespan study with full histopathology|No information on individuals available for this study
		
